AdvaCare is a GMP manufacturer of Perphenazine tablets.
Perphenazine tablets are an antipsychotic drug. It is a piperazinyl phenothiazine that has been used clinically for decades. It is five times as potent as chlorpromazine, thus making it a medium-potency antipsychotic.
Perphenazine tablets can be used to treat depression, in combination with an antidepressant, in low doses. It has no intrinsic antidepressive activity. It can also be used as a tranquilizer in patients with known history of drug and/or alcohol addiction. Perphenazine has anxiolytic and sedating properties that make it useful to treat agitated psychotic patients. It can also treat catatonia, a life-threatening state of agitation, in high doses. It can be used in combination with electroconvulsive therapy.
Perphenazine works by blocking dopamine receptors, reducing the excess of dopamine in the brain. This reduces psychotic symptoms such as hallucinations and delusions. It blocks dopamine and histamine-1 receptors in the chemoreceptor trigger zone, thus relieving nausea and vomiting. It also binds to alpha-adrenergic receptors. It is a phenothiazine derivative with antiemetic and antipsychotic properties.
As with all pharmaceuticals, some unwanted effects can occur from the use of perphenazine tablets. Always consult a doctor or health care professional for medical advice before use. Common side effects include, but may not be limited to movement problems, sleepiness, dry mouth, low blood pressure, and increased weight. Seek medical attention if the following develop: signs of an allergic reaction, low white blood cell levels, and tardive dyskinesia.
For a comprehensive list of all possible effects, consult your doctor. If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.